What Is Tirzepatide?

Tirzepatide is a synthetic peptide molecule designed to activate both GIP
and GLP-1 receptors. These receptors are involved in incretin signalling,
glucose regulation and other physiological processes.

Unlike medicines that selectively target only the GLP-1 receptor, tirzepatide
combines activity at two incretin-related receptors. This dual mechanism is
one of the main characteristics that has attracted scientific interest in
the compound.

Peer-reviewed literature has examined tirzepatide’s pharmacological
characteristics, clinical development and activity as a dual GIP/GLP-1
receptor agonist. Researchers can review the

scientific literature on tirzepatide and dual GIP/GLP-1 receptor activity

through PubMed.

Tirzepatide and GIP/GLP-1 Research

GIP and GLP-1 are incretin hormones involved in physiological processes
associated with nutrient intake and metabolic regulation. Tirzepatide’s
ability to interact with both receptor systems provides a useful area of
investigation for researchers studying incretin biology.

Published research has investigated tirzepatide across different clinical
and pharmacological settings. The available evidence includes studies of
glycaemic control, body-weight outcomes and other metabolic parameters.
These findings should always be interpreted within the context of the
specific study design and population.

The

PubMed review of tirzepatide research

provides additional background on its dual GIP and GLP-1 receptor activity
and clinical development.

Tirzepatide Research Peptide Information

Researchers considering a tirzepatide research peptide
should review the specific product information provided on this page before
ordering.

Product-specific considerations may include the available quantity,
presentation, storage information where provided, ordering requirements and
applicable fulfilment arrangements.

For information concerning delivery and fulfilment, please review the

Anglo Peptides Shipping Policy
.

Tirzepatide in the UK

Tirzepatide has an established regulatory history in the United Kingdom.
The Medicines and Healthcare products Regulatory Agency (MHRA) authorised
Mounjaro (tirzepatide) for weight management in specified adults in 2023,
following its earlier use in the treatment of type 2 diabetes.

The MHRA’s current guidance identifies tirzepatide as a dual GLP-1 and
GIP receptor agonist and explains the licensed medical uses of Mounjaro.
You can review the current

MHRA guidance on GLP-1 and related medicines

for authoritative UK information.

The regulatory status of an authorised medicinal product should not be
confused with the status or intended use of a research-use product offered
through an online research catalogue.

Why Researchers Explore Tirzepatide

The dual-receptor profile of tirzepatide provides a distinctive research
model for investigating interactions between GIP and GLP-1 signalling.
Researchers may examine the compound within broader areas of metabolic and
endocrine science.

Its extensive research history also means that tirzepatide has been studied
across multiple clinical programmes, providing a substantial scientific
literature base for researchers seeking background information.

For comparison with another peptide being investigated in metabolic
research, explore our

Retatrutide research product
.

Explore Related Research Products

Researchers exploring peptide science can also review other products within
the Anglo Peptides catalogue that relate to different areas of metabolic,
endocrine or peptide research.

• 
  Retatrutide research peptide
  
  – an investigational compound with a distinct receptor profile.
• 
  MOTS-c peptide
  
  – a peptide associated with mitochondrial and metabolic research.
• 
  AOD-9604 peptide
  
  – another peptide research material within the catalogue.
• 
  CJC-1295 + Ipamorelin
  
  – a combination product associated with research into peptide and
  growth-hormone signalling.

Browse the complete

research peptide collection

to explore additional products.

Product Ordering Information

Before placing an order, review the product information available on this
page and ensure that the intended purchase is appropriate for your
legitimate research requirements.

Customers should also review the applicable shipping information and ensure
that any purchase, possession, handling and intended research activity
complies with the laws and regulations applicable to their location.

To explore the wider catalogue, visit the

Anglo Peptides Shop
.

Research-Use Notice

This product is supplied strictly for legitimate research purposes.
It is not intended for human consumption, self-administration, diagnosis,
treatment or prevention of disease.

Anglo Peptides does not provide dosing instructions, treatment protocols or
medical advice. Researchers and customers are responsible for ensuring that
their intended purchase, handling and research activities comply with all
applicable laws, regulations and institutional requirements.